Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Identification of antifungal natural products via Saccharomyces cerevisiae bioassay: Insights into macrotetrolide drug spectrum, potency and mode of action

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Tebbets, B.
  • Yu, Z. G.
  • Stewart, D.
  • Zhao, L. X.
  • Jiang, Y.
  • Xu, L. H.
  • Andes, D.
  • Shen, Ben
  • Klein, B.

publication date

  • April 2013

journal

  • Medical Mycology  Journal

abstract

  • Since current antifungal drugs have not kept pace with the escalating medical demands of fungal infections, new, effective medications are required. However, antifungal drug discovery is hindered by the evolutionary similarity of mammalian and fungal cells, which results in fungal drug targets having human homologs and drug non-selectivity. The group III hybrid histidine kinases (HHKs) are an attractive drug target since they are conserved in fungi and absent in mammals. We used a Saccharomyces cerevisiae reporter strain that conditionally expresses HHK to establish a high-throughput bioassay to screen microbial extracts natural products for antifungals. We identified macrotetrolides, a group of related ionophores thought to exhibit restricted antifungal activity. In addition to confirming the use of this bioassay for the discovery of antifungal natural products, we demonstrated broader, more potent fungistatic activity of the macrotetrolides against multiple Candida spp., Cryptococcus spp., and Candida albicans in biofilms. Macrotetrolides were also active in an animal model of C. albicans biofilm, but were found to have inconsistent activity against fluconazole-resistant C. albicans, with most isolates resistant to this natural product. The macrotetrolides do not directly target HHKs, but their selective activity against S. cerevisiae grown in galactose (regardless of Drk1 expression) revealed potential new insight into the role of ion transport in the mode of action of these promising antifungal compounds. Thus, this simple, high-throughput bioassay permitted us to screen microbial extracts, identify natural products as antifungal drugs, and expand our understanding of the activity of macrotetrolides.

subject areas

  • Antifungal Agents
  • Biological Assay
  • Biological Products
  • Candida
  • Cryptococcus
  • Drug Evaluation, Preclinical
  • Genes, Reporter
  • Ion Transport
  • Lactones
  • Microbial Sensitivity Tests
  • Protein Kinases
  • Saccharomyces cerevisiae
scroll to property group menus

Research

keywords

  • Fungi
  • drug discovery
  • macrotetrolide
  • natural products
  • reporter
scroll to property group menus

Identity

PubMed Central ID

  • PMC3594352

International Standard Serial Number (ISSN)

  • 1369-3786

Digital Object Identifier (DOI)

  • 10.3109/13693786.2012.710917

PubMed ID

  • 22928922
scroll to property group menus

Additional Document Info

start page

  • 280

end page

  • 289

volume

  • 51

issue

  • 3

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support